logo-loader
RNS
capAI PLC

Capai PLC - Issue of Equivalent Shares and PDMR Notification

RNS Number : 9000L
Capai PLC
09 June 2025
 

THIS ANNOUNCEMENT ("ANNOUNCEMENT") AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, ITS STATES, TERRITORIES AND POSSESSIONS, AUSTRALIA, CANADA, JAPAN, SINGAPORE, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY ANY APPLICABLE LAW.

9 June 2025

capAI plc
("capAI" or the "Company")

Allotment and Issue of Equivalent Shares and PDMR Notification

capAI plc (LSE: CPAI) announces that, further to its announcement on 29 May 2025 (RNS Number : 5031K) of its entry into the Stock Loan Agreement with Richard Andrew Edwards, a Director designated as Executive Chairman, it has today allotted and issued 400,000,000 Equivalent Shares to Mr Edwards in satisfaction of the Company's obligations to deliver such new Ordinary Shares under the Stock Loan Agreement.

The Equivalent Shares have been issued and allotted to Mr. Edwards under an exemption from the requirement to issue a prospectus. The Equivalent Shares rank pari passu with the existing Ordinary Shares and, have today been admitted to the equity shares (transition) category of the Official List of the FCA and to trading on the main market for listed securities of London Stock Exchange plc ("Admission").

Following Admission, the Company has 3,631,830,636 Ordinary Shares in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company are 3,631,830,636.

The above figure of 3,631,830,636 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

As previously announced, the Company expects to publish its interim results for the period to 31 March 2025 on 30 June 2025 and therefore the Company has been in a closed period (for the purposes of Regulation 2014/596/EU, which is part of the domestic law of the United Kingdom of Great Britain and Northern Ireland pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310) ("UK MAR")) since 31 May 2025. The Company notes that all actions as outlined in the circular published by the Company and posted to Shareholders on 2 May 2025 (the "Circular") and the transactions envisaged by the Stock Loan Agreement on the dates specified, including the allotment and issue of the Equivalent Shares to Richard Edwards, would be compliant with UK MAR as the only actions within the closed period would be the implementation of actions resulting from irrevocable decisions made by the Board prior to the commencement of the closed period (for the purposes of UK MAR).

Capitalised terms in this Announcement have the meaning ascribed to them in the Definitions section of the Circular, unless otherwise defined in this Announcement.

 

For further information, please contact:

Company:
capAI plc hello@capaiplc.com

Broker Enquiries:
Peterhouse Capital Limited Tel: +44 (0) 207 469 0930



 

The information set out below is provided in accordance with the requirements of Article 19(3) of UK MAR.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Edwards

2

Reason for Notification

a)

Position/status

Executive Director, PDMR

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

capAI plc

b)

LEI

213800IVPZ932NP24O44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares


Identification code

GB00BMWC6Q55

b)

Nature of the transaction

Issue of new ordinary shares (Equivalent Shares) pursuant to the Stock Loan Agreement dated 28 May 2025

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

400,000,000

d)

Aggregated information



- Aggregated volume

400,000,000


- Price

N/A

e)

Date of the transaction

9 June 2025

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEKZGGVGNGGKZM
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read